{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T09:12:38Z","timestamp":1788599558232,"version":"build-2803163510"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bmc.2026.118781","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T07:11:11Z","timestamp":1787209871000},"page":"118781","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Targeting SIRT6: the design and therapeutic implications of activators and inhibitors"],"prefix":"10.1016","volume":"142","author":[{"given":"Yuxin","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofan","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuben","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bmc.2026.118781_bb0005","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1006\/bbrc.2000.3000","article-title":"Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins","volume":"273","author":"Frye","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"10.1016\/j.bmc.2026.118781_bb0010","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2004-5-5-224","article-title":"Sirtuins: Sir2-related NAD-dependent protein deacetylases","volume":"5","author":"North","year":"2004","journal-title":"Genome Biol"},{"issue":"10","key":"10.1016\/j.bmc.2026.118781_bb0015","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.1091\/mbc.e05-01-0033","article-title":"Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins","volume":"16","author":"Michishita","year":"2005","journal-title":"Mol Biol Cell"},{"issue":"19","key":"10.1016\/j.bmc.2026.118781_bb0020","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20194945","article-title":"Sirtuins and SIRT6 in carcinogenesis and in diet","volume":"20","author":"de C\u00e9u Teixeira","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.bmc.2026.118781_bb0025","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.tibs.2010.07.009","article-title":"Chromatin regulation and genome maintenance by mammalian SIRT6","volume":"36","author":"Tennen","year":"2011","journal-title":"Trends Biochem Sci"},{"issue":"1","key":"10.1016\/j.bmc.2026.118781_bb0030","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00018-021-04061-9","article-title":"Roles of SIRT6 in kidney disease: a novel therapeutic target","volume":"79","author":"Yang","year":"2021","journal-title":"Cell Mol Life Sci"},{"issue":"43","key":"10.1016\/j.bmc.2026.118781_bb0035","doi-asserted-by":"crossref","first-page":"31350","DOI":"10.1074\/jbc.C113.511261","article-title":"Activation of the protein deacetylase SIRT6 by long-chain fatty acids and widespread deacylation by mammalian sirtuins","volume":"288","author":"Feldman","year":"2013","journal-title":"J Biol Chem"},{"issue":"22","key":"10.1016\/j.bmc.2026.118781_bb0040","doi-asserted-by":"crossref","first-page":"21313","DOI":"10.1074\/jbc.M413296200","article-title":"Mouse Sir2 homolog SIRT6 is a nuclear ADP-ribosyltransferase","volume":"280","author":"Liszt","year":"2005","journal-title":"J Biol Chem"},{"issue":"7","key":"10.1016\/j.bmc.2026.118781_bb0045","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1096\/fj.201601294R","article-title":"Pharmacological Sirt6 inhibition improves glucose tolerance in a type 2 diabetes mouse model","volume":"31","author":"Sociali","year":"2017","journal-title":"FASEB J"},{"key":"10.1016\/j.bmc.2026.118781_bb0050","article-title":"SIRT6 widely regulates aging, immunity, and cancer","volume":"12","author":"Li","year":"2022","journal-title":"Front Oncol"},{"issue":"6","key":"10.1016\/j.bmc.2026.118781_bb0055","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.cell.2012.10.047","article-title":"The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism","volume":"151","author":"Sebasti\u00e1n","year":"2012","journal-title":"Cell"},{"issue":"16","key":"10.1016\/j.bmc.2026.118781_bb0060","doi-asserted-by":"crossref","first-page":"14575","DOI":"10.1074\/jbc.M111.218990","article-title":"Structure and biochemical functions of SIRT6","volume":"286","author":"Pan","year":"2011","journal-title":"J Biol Chem"},{"issue":"8","key":"10.1016\/j.bmc.2026.118781_bb0065","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.bbapap.2009.09.009","article-title":"Structural basis for sirtuin function: what we know and what we don\u2019t","volume":"1804","author":"Sanders","year":"2010","journal-title":"Biochim Biophys Acta"},{"issue":"7443","key":"10.1016\/j.bmc.2026.118781_bb0070","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature12038","article-title":"SIRT6 regulates TNF-\u03b1 secretion through hydrolysis of long-chain fatty acyl lysine","volume":"496","author":"Jiang","year":"2013","journal-title":"Nature"},{"issue":"13","key":"10.1016\/j.bmc.2026.118781_bb0075","doi-asserted-by":"crossref","first-page":"5845","DOI":"10.7150\/thno.44043","article-title":"Small-molecule activating SIRT6 elicits therapeutic effects and synergistically promotes anti-tumor activity of vitamin D(3) in colorectal cancer","volume":"10","author":"Shang","year":"2020","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.bmc.2026.118781_bb0080","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41401-020-0442-2","article-title":"MDL-800, an allosteric activator of SIRT6, suppresses proliferation and enhances EGFR-TKIs therapy in non-small cell lung cancer","volume":"42","author":"Shang","year":"2021","journal-title":"Acta Pharmacol Sin"},{"issue":"3","key":"10.1016\/j.bmc.2026.118781_bb0085","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1006\/bbrc.2000.3854","article-title":"Role of NAD(+) in the deacetylase activity of the SIR2-like proteins","volume":"278","author":"Landry","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"issue":"26","key":"10.1016\/j.bmc.2026.118781_bb0090","doi-asserted-by":"crossref","first-page":"14178","DOI":"10.1073\/pnas.250422697","article-title":"Silent information regulator 2 family of NAD- dependent histone\/protein deacetylases generates a unique product, 1-O-acetyl-ADP-ribose","volume":"97","author":"Tanner","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.bmc.2026.118781_bb0095","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cell.2008.10.052","article-title":"SIRT6 links histone H3 lysine 9 deacetylation to NF-kappaB-dependent gene expression and organismal life span","volume":"136","author":"Kawahara","year":"2009","journal-title":"Cell"},{"issue":"7186","key":"10.1016\/j.bmc.2026.118781_bb0100","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/nature06736","article-title":"SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin","volume":"452","author":"Michishita","year":"2008","journal-title":"Nature"},{"issue":"16","key":"10.1016\/j.bmc.2026.118781_bb0105","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.4161\/cc.8.16.9367","article-title":"Cell cycle-dependent deacetylation of telomeric histone H3 lysine K56 by human SIRT6","volume":"8","author":"Michishita","year":"2009","journal-title":"Cell Cycle"},{"issue":"5","key":"10.1016\/j.bmc.2026.118781_bb0110","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/nsmb.3202","article-title":"SIRT6 deacetylates H3K18ac at pericentric chromatin to prevent mitotic errors and cellular senescence","volume":"23","author":"Tasselli","year":"2016","journal-title":"Nat Struct Mol Biol"},{"issue":"7","key":"10.1016\/j.bmc.2026.118781_bb0115","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1021\/acschembio.6b00243","article-title":"A chemical biology approach to reveal Sirt6-targeted histone H3 sites in nucleosomes","volume":"11","author":"Wang","year":"2016","journal-title":"ACS Chem Biol"},{"issue":"18","key":"10.1016\/j.bmc.2026.118781_bb0120","doi-asserted-by":"crossref","first-page":"8537","DOI":"10.1093\/nar\/gkt642","article-title":"SIRT6 exhibits nucleosome-dependent deacetylase activity","volume":"41","author":"Gil","year":"2013","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"10.1016\/j.bmc.2026.118781_bb0125","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/nchembio.2106","article-title":"Identifying the functional contribution of the defatty-acylase activity of SIRT6","volume":"12","author":"Zhang","year":"2016","journal-title":"Nat Chem Biol"},{"issue":"13","key":"10.1016\/j.bmc.2026.118781_bb0130","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1021\/bi802093g","article-title":"Investigating the ADP-ribosyltransferase activity of sirtuins with NAD analogues and 32P-NAD","volume":"48","author":"Du","year":"2009","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/j.bmc.2026.118781_bb0135","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.tem.2016.10.002","article-title":"SIRT6: novel mechanisms and links to aging and disease","volume":"28","author":"Tasselli","year":"2017","journal-title":"Trends Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.bmc.2026.118781_bb0140","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.250181","article-title":"Histidine and tyrosine residues are targets for SIRT6 ADP-ribosylation activity","volume":"16","author":"Rack","year":"2026","journal-title":"Open Biol"},{"issue":"5","key":"10.1016\/j.bmc.2026.118781_bb0145","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/cas.12632","article-title":"Sirtuin 6 promotes transforming growth factor-\u03b21\/H2O2\/HOCl-mediated enhancement of hepatocellular carcinoma cell tumorigenicity by suppressing cellular senescence","volume":"106","author":"Feng","year":"2015","journal-title":"Cancer Sci"},{"issue":"13","key":"10.1016\/j.bmc.2026.118781_bb0150","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1158\/1078-0432.CCR-15-1638","article-title":"SIRT6 overexpression potentiates apoptosis evasion in hepatocellular carcinoma via BCL2-associated X protein-dependent apoptotic pathway","volume":"22","author":"Ran","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.bmc.2026.118781_bb0155","doi-asserted-by":"crossref","DOI":"10.1186\/s40478-018-0625-y","article-title":"Nicotine promotes neuron survival and partially protects from Parkinson\u2019s disease by suppressing SIRT6","volume":"6","author":"Nicholatos","year":"2018","journal-title":"Acta Neuropathol Commun"},{"issue":"12","key":"10.1016\/j.bmc.2026.118781_bb0160","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1038\/s41401-020-0387-5","article-title":"Downregulation of hippocampal SIRT6 activates AKT\/CRMP2 signaling and ameliorates chronic stress-induced depression-like behavior in mice","volume":"41","author":"Li","year":"2020","journal-title":"Acta Pharmacol Sin"},{"issue":"4","key":"10.1016\/j.bmc.2026.118781_bb0165","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/anie.201610082","article-title":"Structural basis of Sirtuin 6 activation by synthetic small molecules","volume":"56","author":"You","year":"2017","journal-title":"Angew Chem Int Ed Eng"},{"issue":"12","key":"10.1016\/j.bmc.2026.118781_bb0170","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/s41589-018-0150-0","article-title":"Identification of a cellularly active SIRT6 allosteric activator","volume":"14","author":"Huang","year":"2018","journal-title":"Nat Chem Biol"},{"issue":"5","key":"10.1016\/j.bmc.2026.118781_bb0175","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.apsb.2020.09.010","article-title":"Mechanism of allosteric activation of SIRT6 revealed by the action of rationally designed activators","volume":"11","author":"Lu","year":"2021","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"10.1016\/j.bmc.2026.118781_bb0180","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-55654-1","article-title":"Structural basis for the activation and inhibition of Sirtuin 6 by quercetin and its derivatives","volume":"9","author":"You","year":"2019","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.bmc.2026.118781_bb0185","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13185","article-title":"The SIRT6 activator MDL-800 improves genomic stability and pluripotency of old murine-derived iPS cells","volume":"19","author":"Chen","year":"2020","journal-title":"Aging Cell"},{"issue":"18","key":"10.1016\/j.bmc.2026.118781_bb0190","doi-asserted-by":"crossref","first-page":"10474","DOI":"10.1021\/acs.jmedchem.0c01183","article-title":"Discovery of potent small-molecule SIRT6 activators: structure-activity relationship and anti-pancreatic ductal adenocarcinoma activity","volume":"63","author":"Chen","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118781_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2023.106424","article-title":"Design, synthesis, and biological screening of a series of pyrazolo [1,5-a]quina-zoline derivatives as SIRT6 activators","volume":"185","author":"Zhang","year":"2023","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"10.1016\/j.bmc.2026.118781_bb0200","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S2468-1253(24)00248-6","article-title":"Safety, clinical activity, pharmacodynamics, and pharmacokinetics of IMU-856, a SIRT6 modulator, in coeliac disease: a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial","volume":"10","author":"Daveson","year":"2025","journal-title":"Lancet Gastroent Hepat"},{"issue":"9","key":"10.1016\/j.bmc.2026.118781_bb0205","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1080\/03007995.2025.2574465","article-title":"A phase 2, multicenter, double-blind, randomized, placebo-controlled study of the safety and efficacy of forvisirvat (SP-624) in the treatment of adults with major depressive disorder","volume":"41","author":"Raskin","year":"2025","journal-title":"Curr Med Res Opin"},{"issue":"3","key":"10.1016\/j.bmc.2026.118781_bb0210","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.apsb.2023.11.014","article-title":"Discovery of a potent and highly selective inhibitor of SIRT6 against pancreatic cancer metastasis in vivo","volume":"14","author":"Xu","year":"2024","journal-title":"Acta Pharm Sin B"},{"issue":"8","key":"10.1016\/j.bmc.2026.118781_bb0215","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22084180","article-title":"A comprehensive analysis into the therapeutic application of natural products as SIRT6 modulators in Alzheimer\u2019s disease, aging, cancer, inflammation, and diabetes","volume":"22","author":"Akter","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"14","key":"10.1016\/j.bmc.2026.118781_bb0220","doi-asserted-by":"crossref","first-page":"9732","DOI":"10.1021\/acs.jmedchem.1c00601","article-title":"Emerging therapeutic potential of SIRT6 modulators","volume":"64","author":"Fiorentino","year":"2021","journal-title":"J Med Chem"},{"issue":"47","key":"10.1016\/j.bmc.2026.118781_bb0225","doi-asserted-by":"crossref","first-page":"45099","DOI":"10.1074\/jbc.M205670200","article-title":"Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast sir2 and human SIRT1","volume":"277","author":"Bitterman","year":"2002","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.bmc.2026.118781_bb0230","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.molcel.2005.02.022","article-title":"Mechanism of sirtuin inhibition by nicotinamide: altering the NAD(+) cosubstrate specificity of a Sir2 enzyme","volume":"17","author":"Avalos","year":"2005","journal-title":"Mol Cell"},{"issue":"4","key":"10.1016\/j.bmc.2026.118781_bb0235","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1039\/b311404j","article-title":"Anthocyanins and other flavonoids","volume":"21","author":"Williams","year":"2004","journal-title":"Nat Prod Rep"},{"key":"10.1016\/j.bmc.2026.118781_bb0240","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.abb.2017.12.009","article-title":"Trichostatin A inhibits deacetylation of histone H3 and p53 by SIRT6","volume":"638","author":"Wood","year":"2018","journal-title":"Arch Biochem Biophys"},{"issue":"23","key":"10.1016\/j.bmc.2026.118781_bb0245","doi-asserted-by":"crossref","first-page":"10922","DOI":"10.1021\/acs.jmedchem.8b01455","article-title":"Structural basis of sirtuin 6 inhibition by the hydroxamate trichostatin A: implications for protein deacylase drug development","volume":"61","author":"You","year":"2018","journal-title":"J Med Chem"},{"issue":"38","key":"10.1016\/j.bmc.2026.118781_bb0250","doi-asserted-by":"crossref","first-page":"7498","DOI":"10.1039\/C4OB00860J","article-title":"Thiomyristoyl peptides as cell-permeable Sirt6 inhibitors","volume":"12","author":"He","year":"2014","journal-title":"Org Biomol Chem"},{"issue":"25","key":"10.1016\/j.bmc.2026.118781_bb0255","doi-asserted-by":"crossref","first-page":"5928","DOI":"10.1039\/C5OB02339D","article-title":"Cyclic peptide-based potent human SIRT6 inhibitors","volume":"14","author":"Liu","year":"2016","journal-title":"Org Biomol Chem"},{"issue":"12","key":"10.1016\/j.bmc.2026.118781_bb0260","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.1016\/j.bmc.2011.01.029","article-title":"Computer- and structure-based lead design for epigenetic targets","volume":"19","author":"Heinke","year":"2011","journal-title":"Bioorg Med Chem"},{"issue":"11","key":"10.1016\/j.bmc.2026.118781_bb0265","doi-asserted-by":"crossref","first-page":"4796","DOI":"10.1021\/jm500487d","article-title":"Discovery of novel and selective SIRT6 inhibitors","volume":"57","author":"Parenti","year":"2014","journal-title":"J Med Chem"},{"issue":"13","key":"10.1016\/j.bmc.2026.118781_bb0270","doi-asserted-by":"crossref","first-page":"5169","DOI":"10.1021\/jacs.8b08039","article-title":"A focused DNA-encoded chemical library for the discovery of inhibitors of NAD(+)-dependent enzymes","volume":"141","author":"Yuen","year":"2019","journal-title":"J Am Chem Soc"},{"issue":"16","key":"10.1016\/j.bmc.2026.118781_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127215","article-title":"Discovery of 5-(4-methylpiperazin-1-yl)-2-nitroaniline derivatives as a new class of SIRT6 inhibitors","volume":"30","author":"Sun","year":"2020","journal-title":"Bioorg Med Chem Lett"},{"issue":"2","key":"10.1016\/j.bmc.2026.118781_bb0280","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.apsb.2021.06.015","article-title":"Targeting a cryptic allosteric site of SIRT6 with small-molecule inhibitors that inhibit the migration of pancreatic cancer cells","volume":"12","author":"Zhang","year":"2022","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"10.1016\/j.bmc.2026.118781_bb0285","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/cbf.3369","article-title":"The PROTAC technology in drug development","volume":"37","author":"Zou","year":"2019","journal-title":"Cell Biochem Funct"},{"issue":"3","key":"10.1016\/j.bmc.2026.118781_bb0290","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","article-title":"PROTAC targeted protein degraders: the past is prologue","volume":"21","author":"B\u00e9k\u00e9s","year":"2022","journal-title":"Nat Rev Drug Discov"},{"issue":"19","key":"10.1016\/j.bmc.2026.118781_bb0295","doi-asserted-by":"crossref","first-page":"17319","DOI":"10.1021\/acs.jmedchem.4c01223","article-title":"Discovery of novel PROTAC SIRT6 degraders with potent efficacy against hepatocellular carcinoma","volume":"67","author":"Huang","year":"2024","journal-title":"J Med Chem"}],"container-title":["Bioorganic &amp; Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089626002373?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089626002373?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T08:37:59Z","timestamp":1788597479000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089626002373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":59,"alternative-id":["S0968089626002373"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118781","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting SIRT6: the design and therapeutic implications of activators and inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118781","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118781"}}